Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 27.0B | 29.8B | 27.7B | 30.9B |
Cost of revenue | 15.5B | 17.4B | 16.2B | 18.6B |
Gross profit | 11.5B | 12.4B | 11.6B | 12.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 5.3B | 5.7B | 5.0B | 5.2B |
Operating income | 3.4B | 3.8B | 3.5B | 4.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 151M | 159.9M | 170.1M | 151.7M |
Other income expense | — | — | — | — |
Pretax income | 3.5B | 3.9B | 3.6B | 4.7B |
Tax provision | 870.2M | 984.4M | 882.5M | 1.1B |
Net income | 2.6B | 3.0B | 2.7B | 3.5B |
Basic EPS | — | 2.5 | 2.3 | 3.0 |
Diluted EPS | — | 2.5 | 2.3 | 3.0 |
Basic average shares | — | 1.2B | 1.2B | 1.2B |
Diluted average shares | — | 1.2B | 1.2B | 1.2B |
EBITDA | 4.5B | 5.0B | 4.6B | 5.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | -8.6M | -8.4M | -2.4M | -4.7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |